Table of Contents 3
List of Tables 5
List of Figures 5
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Inovio Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Inovio Pharma Acquires DNA Therapies For Alzheimer's Disease And Multiple Sclerosis From Fudan University 13
Partnerships 14
Inovio Pharma Enters into Partnership with AIDS Malignancy Consortium 14
Inovio Pharma Enters into Partnership with Coalition for Epidemic Preparedness Innovations 15
Inovio Pharma and Parker Institute for Cancer Immunotherapy Enter into Agreement 16
Inovio Pharma Enters into Agreement with Genentech 17
Inovio Pharma and Regeneron Pharma Enter into Agreement 18
Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 19
Inovio Pharma Enters into Research Agreement with Wistar Institute 20
GeneOne Life Science Enters into Research Agreement with Inovio Pharma 21
Inovio Pharma Enters into Co-Development Agreement with GeneOne Life Science 22
Inovio Pharma Amends Agreement with GeneOne 23
Path Malaria Vaccine Initiative And Inovio Pharma Partner To Accelerate Malaria Vaccine Development And Delivery Technologies 24
Licensing Agreements 25
MedImmune Enters into Licensing Agreement with Inovio Pharma 25
Equity Offering 26
Inovio Pharma Plans to Raise up to USD250 Million in Public Offering of Shares 26
Inovio Pharma Raises USD75 Million in Public Offering of Shares 27
Inovio Pharma to Raise up to USD35 Million in Private Placement of Shares 29
Inovio Pharma Raises USD6.3 Million in Public Offering of Shares 30
Inovio Pharma Raises USD87.4 Million Public Offering of Shares 31
Inovio Pharma Completes Public Offering Of Shares For US$63.3 Million 33
Inovio Pharma Completes Public Offering Of Common Stock And Warrants For US$15 Million 34
Inovio Pharmaceuticals Inc - Key Competitors 36
Inovio Pharmaceuticals Inc - Key Employees 37
Inovio Pharmaceuticals Inc - Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 40
Financial Announcements 40
Aug 07, 2018: Inovio Pharmaceuticals reports 2018 second quarter financial results 40
May 09, 2018: Inovio Pharmaceuticals Reports 2018 First Quarter Financial Results 42
Mar 14, 2018: Inovio Pharmaceuticals Reports 2017 Fourth Quarter and Year End Financial Results 44
Nov 08, 2017: Inovio Pharmaceuticals Reports 2017 Third Quarter Financial Results 47
Aug 08, 2017: Inovio Pharmaceuticals Reports 2017 Second Quarter Financial Results 50
May 10, 2017: Inovio Pharmaceuticals Reports 2017 First Quarter Financial Results 53
Mar 15, 2017: Inovio Pharmaceuticals Reports 2016 Fourth Quarter and Year End Financial Results 55
Corporate Communications 58
May 24, 2018: Inovio Boosts Leadership Focused on Partnership and Grant Funding By Appointing Two New VPs for Business Development and R&D 58
Dec 11, 2017: Inovio Pharmaceuticals Promotes Dr. Laurent Humeau to Senior Vice President, Research & Development 59
Dec 06, 2017: Inovio Pharmaceuticals Appoints Wendy Yarno To its Board of Directors 60
Jun 28, 2017: Inovio Announces Leadership Appointments 61
Mar 21, 2017: George Bickerstaff Elected to Inovio's Board of Directors 62
Government and Public Interest 63
Feb 12, 2018: Inovio and The Wistar Institute Receive More Than $4.6 Million in R&D Funding to Advance Vaccines Against Tuberculosis & Malaria 63
Jan 18, 2018: The Wistar Institute Awarded More Than $1.4 Million to Create a Malaria Vaccine Through Synthetic DNA-Based Technology 64
Product News 65
Oct 08, 2018: Inovio Successfully Develops First DNA-Encoded Monoclonal Antibody (dMAb) Checkpoint Inhibitor and Demonstrates Tumor Shrinkage in Preclinical Studies 65
Sep 21, 2017: Inovio dMAb Constructs Shrink Prostate Tumors and Protect Against Lethal Antibiotic-Resistant Bacterial Infection In Preclinical Studies 67
09/18/2017: Inovio and Partners Initiate Phase 1/2a Clinical Trial To Further Advance Its Vaccine Against Deadly MERS Infection 69
Jul 06, 2017: Inovio's DNA-based Monoclonal Antibody Platform Achieves Further Proof-of-Principle Validation 70
Feb 27, 2017: Inovio's SynCon WT1 Cancer Antigen Breaks Tolerance, Highlights Potential for Universal Cancer Immunotherapy 72
Clinical Trials 74
May 21, 2018: Inovio Opens Phase 2 Trial for VGX-3100 in Third Indication To Treat HPV - The No. 1 Sexually Transmitted Disease 74
Nov 29, 2017: Inovio's Further Analysis of VGX-3100 Phase 2b Data Reveals Immune Correlates and Biomarker Signatures That Predicted Clinical Efficacy 75
Oct 24, 2017: Inovio and U.S. Army Co-developing Novel Vaccine That Completely Prevents Lethal Lassa Fever Infection in Pre-Clinical Study 77
Jun 08, 2017: Inovio Begins Phase 3 Clinical Trial of VGX-3100 for the Treatment of HPV-Related Cervical Pre-Cancer 78
Apr 24, 2017: Inovio Initiates Phase 2 Efficacy Trial with VGX-3100 For HPV-Related Vulvar Pre-Cancers 80
Feb 23, 2017: Inovio Reports New Positive Clinical Data on MERS Vaccine GLS-5300 81
Other Significant Developments 82
Jan 22, 2018: Inovio Pharmaceuticals' Published Universal Flu Vaccine Data Demonstrates Protective Responses Against All Major, Lethal H1N1 Influenza Viruses From the Last 100 Years in Animal Models 82
Appendix 83
Methodology 83
About GlobalData 83
Contact Us 83
Disclaimer 83

List of Tables
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Inovio Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Inovio Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Inovio Pharma Acquires DNA Therapies For Alzheimer's Disease And Multiple Sclerosis From Fudan University 13
Inovio Pharma Enters into Partnership with AIDS Malignancy Consortium 14
Inovio Pharma Enters into Partnership with Coalition for Epidemic Preparedness Innovations 15
Inovio Pharma and Parker Institute for Cancer Immunotherapy Enter into Agreement 16
Inovio Pharma Enters into Agreement with Genentech 17
Inovio Pharma and Regeneron Pharma Enter into Agreement 18
Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 19
Inovio Pharma Enters into Research Agreement with Wistar Institute 20
GeneOne Life Science Enters into Research Agreement with Inovio Pharma 21
Inovio Pharma Enters into Co-Development Agreement with GeneOne Life Science 22
Inovio Pharma Amends Agreement with GeneOne 23
Path Malaria Vaccine Initiative And Inovio Pharma Partner To Accelerate Malaria Vaccine Development And Delivery Technologies 24
MedImmune Enters into Licensing Agreement with Inovio Pharma 25
Inovio Pharma Plans to Raise up to USD250 Million in Public Offering of Shares 26
Inovio Pharma Raises USD75 Million in Public Offering of Shares 27
Inovio Pharma to Raise up to USD35 Million in Private Placement of Shares 29
Inovio Pharma Raises USD6.3 Million in Public Offering of Shares 30
Inovio Pharma Raises USD87.4 Million Public Offering of Shares 31
Inovio Pharma Completes Public Offering Of Shares For US$63.3 Million 33
Inovio Pharma Completes Public Offering Of Common Stock And Warrants For US$15 Million 34
Inovio Pharmaceuticals Inc, Key Competitors 36
Inovio Pharmaceuticals Inc, Key Employees 37
Inovio Pharmaceuticals Inc, Subsidiaries 39

List of Figures
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Inovio Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10